Back
Morphic Holding Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
62
MORF
Morphic Holding
Last Price:
28.01
Seasonality Move:
28.92%
Sell
11
NBY
NovaBay Pharmaceuticals
Last Price:
0.08
Seasonality Move:
-9.04%
Buy
62
Morphic Holding (MORF)
is a Buy
Is Morphic Holding a Buy, Sell or Hold?
- The current Morphic Holding [MORF] share price is $27.98. The Score for MORF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- MORF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
11
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.08. The Score for NBY is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
MORF Stock Price Chart
What is Morphic Holding's stock price today?
-
The Morphic Holding share price today is $27.98
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MORF is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
MORF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.74 | Sell |
Relative Strength Index (14 RSI): | 34.81 | Sell |
Chaikin Money Flow: | 213333 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.05 - 33.85) | Sell |
Bollinger Bands (100): | (27.12 - 35.82) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 28.33 | Sell |
Chaikin Money Flow: | 212946 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.09 - 0.13) | Sell |
Bollinger Bands (100): | (0.11 - 0.23) | Sell |
MORF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.72 | Sell |
20-day SMA: | 30.75 | Sell |
50-day SMA: | 34.26 | Sell |
200-day SMA: | 35.92 | Sell |
8-day EMA: | 28.68 | Sell |
20-day EMA: | 30.45 | Sell |
50-day EMA: | 32.06 | Sell |
200-day EMA: | 34.48 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.09 | Sell |
20-day SMA: | 0.1 | Sell |
50-day SMA: | 0.13 | Sell |
200-day SMA: | 0.35 | Sell |
8-day EMA: | 0.09 | Sell |
20-day EMA: | 0.1 | Sell |
50-day EMA: | 0.13 | Sell |
200-day EMA: | 0.59 | Sell |
Morphic Holding Earnings Growth & MORF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.59 per share, and a decrease next year of $0.44 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.04 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Morphic Holding Technical Analysis
Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |